A groundbreaking diagnostic tool has been developed by a team of researchers from University College London and the University Medical Center Goettingen in Germany, leveraging the capabilities of artificial intelligence to achieve unprecedented accuracy and efficiency in medical testing.
Published in the journal Nature Communications, the study examined 72 patients diagnosed with idiopathic rapid eye movement behavior disorder (iRBD), a condition known to increase the likelihood of developing Alzheimer’s disease, Fox reported.
By applying machine learning techniques to analyze blood samples from the patients, the researchers found that 79 per cent of the participants exhibited the same biomarkers commonly found in individuals with Parkinson’s disease.
During a decade-long follow-up period, the researchers observed that 16 of the patients eventually developed Parkinson’s disease, a neurodegenerative movement disorder that impacts nearly one million individuals in the United States.
FAQs:
Q1. What is the full form of AI?
A1. The full form of AI is Artificial Intelligence.Q2. What is Parkinson’s disease?
A2. Parkinson’s disease is a neurodegenerative movement disorder that impacts nearly one million individuals in the United States.
Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not guarantee, vouch for or endorse any of its contents nor is responsible for them in any manner whatsoever. Please take all steps necessary to ascertain that any information and content provided is correct, updated, and verified. ET hereby disclaims any and all warranties, express or implied, relating to the report and any content therein.
This news item came from: https://economictimes.indiatimes.com/news/international/us/parkinsons-disease-blood-test-may-predict-disease-well-before-symptoms/articleshow/111196225.cms
